Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen-Positron Emission Tomography era.
PSMA PET
multiparametric MRI
prostate cancer
vanishing cancer
Journal
IJU case reports
ISSN: 2577-171X
Titre abrégé: IJU Case Rep
Pays: Australia
ID NLM: 101764958
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
28
12
2022
accepted:
18
07
2023
medline:
6
11
2023
pubmed:
6
11
2023
entrez:
6
11
2023
Statut:
epublish
Résumé
The absence of prostate cancer on final surgical pathology after biopsy-proven prostate cancer is a rare finding. Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound-guided biopsy in a man who underwent both magnetic resonance imaging and pT0 prostate cancer is rare. The use of novel imaging modalities may help in the workup of prostate cancer.
Identifiants
pubmed: 37928279
doi: 10.1002/iju5.12614
pii: IJU512614
pmc: PMC10622191
doi:
Types de publication
Case Reports
Langues
eng
Pagination
337-340Informations de copyright
© 2023 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
J Urol. 2020 Apr;203(4):706-712
pubmed: 31642740
Eur Urol. 2022 Aug;82(2):156-160
pubmed: 34887117
Curr Oncol. 2022 Feb 23;29(3):1309-1315
pubmed: 35323311
Can Urol Assoc J. 2022 Feb;16(2):16-23
pubmed: 35133265
Arch Pathol Lab Med. 2006 Jun;130(6):811-6
pubmed: 16740032